Panic disorder: Clinical features and treatment approaches


如何引用文章

全文:

详细

The paper reviews scientific publications on studies of the epidemiology, etiology, pathogenesis, and main clinical manifestations of panic disorders and approaches to their treatment.

全文:

Паническое расстройство. Клинические особенности и подходы к лечению. - Аннотация. В статье представлен обзор научных публикаций, посвященных изучению эпидемиологии, этиологии, патогенеза, основных клинических проявлений и подходов к лечению панических расстройств.
×

作者简介

L Chutko

Email: chutko5@mail.ru

S Surushkina

参考

  1. Вейн А.М., Дюкова Г.М., Воробьева О.В., Данилов А.Б. Панические атаки (неврологические и психофизиологические аспекты). СПб: Ин-т мед маркетинга 1997; 304.
  2. Wittchen H.-U., Essau C.A. Epidemiology of panic disorder: Progress and unresolved issues. J Psych Res 1993; 27 (Suppl. 1): 47-68.
  3. Westenberg H.G., Liebowitz M.R. Overview of panic and social anxiety disorders. J Clin Psychiatr 2004; 65 (Suppl. 14): 22-26.
  4. Kessler R.C., Chiu W.T., Jin R. et al. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatr 2006; 63: 415-424.
  5. Skapinakis P., Lewis G., Davies S. et al. Singleton Panic disorder and subthreshold panic in the UK general population: epidemiology, comorbidity and functional limitation. Eur Psychiatr 2011; 26 (6): 354-362.
  6. Batelaan N.M., De Graaf R., Van Balkom A.J. et al. Epidemiology of panic. Jijdschr Psychiatr 2006; 48 (3): 195-205.
  7. Klerman G.L., Weissman M.M., Ouellette R. et al. Panic attacks in the community: Social morbidity and health care utilization.
  8. Tilli V., Suominen K., Karlsson H. Panic disorder in primary care: Comorbid psychiatric disorders and their persistence. Scand J Primary Health Care 2012; 30: 247-253.
  9. Diler R.S. Panic disorder in children and adolescents. Yonsei Medical J 2003; 44 (1): 174-179.
  10. Ollendick T.H., Mattis J.L., King N.J. Panic in children and adolescents: A rewiew. J Child Psychol Psychiatr 1994; 35: 133-134.
  11. Angst J., Wicki W. The Zurich Study. XIII. Recurrent brief anxiety. Eur Arch Psychiatry Clin Neurosci 1992; 241 (5): 296-300.
  12. Sheikh J.I., Leskin G.A., Klein D.F. Gender differences in panic disorder: Findings from the National Comorbidity Survey. Am J Psychiatr 2002; 159 (1): 55-58.
  13. Finn C.T., Smoller J.V. The genetics of panic disorder. Curr Psychiatry Rep 2001; 3 (2): 131-137.
  14. Na Hae-Ran, Kang Eun-Ho, Lee Jae-Hon, Yu Bum-Hee. The Genetic Basis of Panic Disorder. J Korean Med Sci 2011; 26: 701-710.
  15. Hamilton S.P., Haghighi F., Heiman G.A. et al. Investigation of dopamine receptor (DRD4) and dopamine transporter (DAT) polymorphisms for genetic linkage or association to panic disorder. Am J Med Genet 2000; 96 (3): 324-330.
  16. Sullivan G.M., Coplan J.D., Kent J.M., Gorman J.M. The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias. Biol Psychiatry 1999; 46 (9): 1205-1218.
  17. Shekhar A., Katner J.S., Sajdyk T.J., Kohl R.R. Role of norepinephrine in the dorsomedial hypothalamic panic response: an in vivo microdialysis study. Pharmacol Biochem Behav 2002; 71 (3): 493-500.
  18. Wise C.D., Berger B.D., Stein L. Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain. Science 1972; 177 (44): 180-183.
  19. Yu S.T., Kim M.K., Kim B. et al. The Effects of 5-HTR1A Polymorphism on Cingulum Connectivity in Patients with Panic Disorder. Psychiatry Investig 2013; 10 (4): 399-406.
  20. Goddard A.W., Mason G.F., Appel M. et al. Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. Am J Psychiatry 2004; 161 (12): 2186-2193.
  21. Rassovsky Y., Kushner M.G. Carbon dioxide in the study of panic disorder: issues of definition, methodology, and outcome. J Anxiety Disord 2003; 17 (1): 1-32.
  22. Uchida R.R., Del-Ben C.M., Santos A.C. et al. Decreased left temporal lobe volume of panic patients measured by magnetic resonance imaging. Braz J Med Biol Res 2003; 36 (7): 925-929.
  23. Akiyoshi J., Hieda K., Aoki Y., Nagayama H. Frontal brain hypoactivity as a biological substrate of anxiety in patients with panic disorders. Neuropsychobiology 2003; 47 (3): 165-170.
  24. Hayano F., Nakamura M., Asami T. et al. Smaller amygdala is associated with anxiety in patients with panic disorder. Psychiatry Clin Neurosci 2009; 63 (3): 66-276.
  25. Kim J.E., Dager S. R., Lyoo In K. The role of the amygdala in the pathophysiology of panic disorder: evidence from neuroimaging studies. Biology Mood Anxiety Dis 2012; 2: 20.
  26. Shear K. Integrating pharmacologic and psychosocial strategies to effectively manage generalized anxiety disorder and panic disorder. CNS Spectr 2004; 9 (9): 9-14.
  27. Beck А.Т., Emery G. Anxiety disorders and phobias. A cognitive perspective. New York: Basic 1985.
  28. Clark D.M. A cognitive approach to panic. Behav Res Ther 1986; 24: 461-470.
  29. Simon N.M., Pollack M.H., Tuby K.S., Stern T.A. Dizziness and panic disorder: a review of the association between vestibular dysfunction and anxiety. Ann Clin Psychiatr 1998; 10 (2): 75-80.
  30. Huffman J.C., Pollack M.H., Stern T.A. Panic disorder and chest pain: Mechanisms, morbidity and management. J Clin Psychiatr 2002; 4 (2): 54-62.
  31. Ветроградова О.П., Довженко Т.В., Васюк Ю.А. Кардиофобический синдром (клиника, динамика, терапия). Клин вестн 1995; 5: 35-37.
  32. Katon W. Panic disorder and somatization: Review of 55 cases. Am J Med 1984; 77: 101-106.
  33. Бройтигам В., Кристиан П., Рад М. Психосоматическая медицина: Пер. с нем. М: ГЭОТАР-Медицина 1999; 373.
  34. Быстрицкий А.С., Незнанов Н.Г., Звартау Э.Э. Дифференциальная диагностика и лечение панических расстройств. Обозр психиатр и мед психол 2006; 3: 4-7.
  35. Aronson T.A., Boque C.I. Phenomenology of Panic Attacks: Descriptive Study of Panic Disorders Patient Self-Reports. Clin Psychiatry 1988; 49 (1): 8-13.
  36. Осипова В.В. Клинико-психовегетативная характеристика и дифференцированная терапия различных форм мигрени: Автореф. дис. … канд. мед. наук. М 1991; 23.
  37. Bajwa W.K., Asnis G.M., Sanderson W.C. et al. High cholesterol levels in patients with panic disorder. Am J Psychiatr 1992; 149 (3): 376-378.
  38. Weissman M.M. The epidemiology of anxiety disorders: rates, risks and familian patterns. J Psychiatr Res 1988; 22 (suppl.): 99-114.
  39. Каплан Г.И., Сэдок Б.Дж. Клиническая психиатрия: В 2 т. Пер. с англ. М: Медицина 1994.
  40. Cosci F. The psychological development of panic disorder: implications for neurobiology and treatment. Rev Bras Psiquiatr 2012; 34: 9-31.
  41. Wilson K.A., Hayward C. A prospective evaluation of agoraphobia and depression symptoms following panic attacks in a community sample of adolescents. J Anxiety Disord 2005; 19 (1): 87-103.
  42. Lydiard R.B., Greenwald S., Weissman M.M. et al. Panic disorder and gastrointestinal symptoms: findings from the NIMH Epidemiologic Catchment Area project. Am J Psychiatr 1994; 151 (1): 64-70.
  43. Torres A.R., Dedomenico A.M., Crepaldi A.L., Miguel E.C. Obsessive-compulsive symptoms in patients with panic disorder. Compr Psychiatr 2004; 45 (3): 219-224.
  44. Warshaw M.G., Dolan R.T., Keller M.B. Suicidal behavior in patients with current or past panic disorder: five years of prospective data from the Harvard/Brown Anxiety Research Program. Am J Psychiatr 2000; 157 (11): 1876-1878.
  45. Stewart S.H., Pihl R.O. Chronic Use of Alcohol and/or Benzodiazepines may account for evidence of altered benzodiazepine receptor sensitivity in anxiety disorder. Arch Gen Psychiatr 1995; 49: 329-333.
  46. Knott V.J. Neuroelectrical activity related to panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 1990; 14 (5): 697-707.
  47. Тутер Н.В. Клинические, нейрофизиологические и психологические особенности панических расстройств у пациентов с неврозами. Журн неврол и психиатр им. С.С. Корсакова 2008; 12: 11-15.
  48. Wiedemann G., Pauli P., Dengler W. et al. Frontal brain asymmetry as a biological substrate of emotions in patients with panic disorders. Arch Gen Psychiatry 1999; 56 (1): 78-84.
  49. Смулевич А.Б. Малопрогредиентная шизофрения и пограничные состояния. М: Медицина 1987; 240.
  50. Филатова Е.Г. Лечение головной боли. Лечение нервных болезней 2000; 2: 3-9.
  51. Warwick H.M. Assessment of hypochondriasis. Behav Res Ther 1995; 33 (7): 845-853.
  52. Шейдер Р., Гринблат Д. Тревожные состояния. Психиатрия. Под ред. Р. Шейдера. М 1998: 353-381.
  53. Сыропятов О.Г., Дзеружинская Н.А., Яновский С.С. Место ноофена в лечении тревожных расстройств у пациентов в общей медицинской практике (аналитический обзор). Україн вісн психоневрол 2004; 1: 90-93.
  54. Чабан О.С., Хаустова Е.А. Терапия пациентов с тревожными синдромами в рамках невротических и психосоматических расстройств. Современные подходы к терапии внутренних болезней. Методическое пособие. Киев 2009.
  55. Морозова О.Г., Ярошевский А.А. Цервикогенная головная боль: современные представления и тактика лечения. Междунар неврол журн 2009; Тематический выпуск: 40-52.
  56. Громов Л.А., Дудко Е.Т. "Типичные" и "атипичные" транквилизаторы. Вестн фармакол и фармац 2003; 10: 11-17.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Consilium Medicum, 2014

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


##common.cookie##